ReviewSummary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward
Under an Elsevier user license
open archive
Keywords
chronic kidney disease (CKD)
classification
complications
guidelines
KDIGO
management
progression
Cited by (0)
AL has received research funding from Abbott, Amgen, Canadian Institutes of Health Research, Genzyme, Kidney Foundation of Canada, Merck and Ortho. AL also has consulting and advising roles for Merck and Otsuka. PES declared no competing interests.
Copyright © 2014 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.